ISB News

Pushing the Molecular Switches of Tuberculosis Into Overdrive to Map Interactions

3 Bullets:

  • Mycobacterium tuberculosis (MTB) infects more than 1.5 billion people worldwide partly due to its ability to sense and adapt to the broad range of hostile environments that exist within hosts.
  • To study how MTB controls its responses at a molecular level, ISB researchers and their collaborators at Seattle Biomed perturbed almost all MTB transcription factor regulators and identified the affected genes.
  • This comprehensive map of molecular switches in MTB provides a basis for understanding control mechanisms and can inform future efforts to rewire MTB responses for more favorable disease outcomes.

By Matt Richards and Shuyi Ma

Mycobacterium tuberculosis (MTB) is the most deadly infectious lung disease, infecting more than 1.8 billion people worldwide and causing 1.3 million deaths each year. Although drugs for MTB exist, they require nearly a year of treatment and have serious side effects. Researchers are searching for more effective treatment targets, but it’s challenging due to a lack of understanding exactly how MTB is able to survive and adapt within the stressful host environment. But, in collaboration with the Sherman lab at Seattle Biomed, ISB researchers have helped put together an important piece of that puzzle. This research was published online on Nov. 3, 2014, in Genome Biology and in Nature Communications on Jan. 12, 2015, in advance of print.

Title: Mapping and manipulating the Mycobacterium tuberculosis transcriptome using a transcription factor overexpression-derived regulatory network
Journal: Genome Biology
Authors: Tige R. Rustad, Kyle J. Minch, Shuyi Ma, Jessica K. Winkler, Samuel Hobbes, Mark J. Hickey, William Brabant, Serdar Turkarslan, Nathan D. Price, Nitin S. Baliga and David R. Sherman
Link: Genome Biology

 

Title: The DNA-binding network of Mycobacterium tuberculosis
Journal: Nature Communications
Authors: Kyle J. Minch, Tige R. Rustad, Eliza J.R. Peterson, Jessica Winkler, David J. Reiss, Shuyi Ma, Mark Hickey, William Brabant, Bob Morrison, Serdar Turkaslan, Chris Mawhinney, James E. Galagan, Nathan D. Price, Nitin S. Baliga, David R. Sherman
Link: Nature Communications

Every organism from bacteria to plants to humans contains a network of genes that work together to control how the organism senses and responds to its environment. The wiring of these regulatory networks is incredibly complex because they consist of hundreds of regulatory genes that interact to control the abundance of thousands of target genes.

MTB employs about 200 different molecular switches to sense and respond to the shifting, hostile landscape of the host. To identify and understand the intertwining gene regulatory network that the molecular switches control, Seattle BioMed and ISB researchers (from the Baliga and Price Labs) examined the consequences of overexpressing (or boosting the function of) each switch. The team overexpressed almost every regulatory gene in MTB, measured the consequences of each perturbation, and used the results to identify genome-wide regulatory interactions for MTB. These results were assembled into an easily searchable map and will stimulate additional systems-level and hypothesis-driven efforts to understand MTB adaptations that promote disease.

Such mappings of regulatory networks are critical for deciphering complexity. This work with MTB has resulted in a valuable tool that may be a stepping stone to developing more effective treatments.

-Eliza Peterson contributed to this report

About Matt Richards and Shuyi Ma: Matt is a graduate student in the Price Lab at ISB. He is a member of ISB’s Editorial Board. Shuyi just received her PhD in the Price Lab at ISB is now a postdoc in the Sherman Lab at Seattle Biomed.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.